Philipj Mease News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Philip J Mease, MD: Bimekizumab Demonstrates Favorable Efficacy Compared with Other DMARDs for PsA

Philip J Mease, MD, highlights recent data comparing the safety and efficacy of bimekizumab with other DMARDs for the treatment of PsA.

Philipj measeSwedish medical centerUniversity of washington school medicineAmerican college of rheumatologyWashington schoolAmerican collegePreferred reporting itemsMatch adjusted indirect comparison

Managing pain should be more than hammering patients with immunomodulatory medications

Managing pain should be more than hammering patients with immunomodulatory medications
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Philip measeByrob volanskyPhilipj measeShenaz baghaUniversity of washingtonSwedish medical centerInternational association for the study of painClinical immunologyBusy clinicianInternational association

New mechanisms, nanobody revolution promising for psoriatic arthritis treatment

New mechanisms, nanobody revolution promising for psoriatic arthritis treatment
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Byjustin cooperPhilipj measeShenaz baghaBristol myers squibbSwedish medical center providence stUniversity of washington school medicineJoseph healthAcelyrin incSwedish medicalWashington schoolClinical immunologyBusy clinician

Tofacitinib improves enthesitis in psoriatic arthritis regardless of baseline severity

Tofacitinib improves enthesitis in psoriatic arthritis regardless of baseline severity
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Shenaz baghaByerich martinPhilipj measeUniversity of washingtonSpondyloarthritis research consortium of canada enthesitis indexSwedish medical centerArthritis researchLeeds enthesitis indexSpondyloarthritis research consortiumCanada enthesitis indexFunctional assessmentChronic illness therapy fatigue

Early benefit with guselkumab predicts lower psoriatic arthritis progression at 2 years

Early benefit with guselkumab predicts lower psoriatic arthritis progression at 2 years
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Philipj measeByerich martinShenaz baghaUniversity of washingtonSwedish medical centerDisease activity index